# Designation of Oripavine as a Basic Class of Controlled Substance; Correction
> **Rule** · Final rule; correcting amendments. · Published 2007-12-10 · 72 FR 69618
## Document
- **Document number:** E7-23759
- **Category:** other
- **Type:** Rule
- **Action:** Final rule; correcting amendments.
- **Citation:** 72 FR 69618
- **Publication date:** 2007-12-10
## Abstract

On September 24, 2007, the Drug Enforcement Administration (DEA) published in the Federal Register a final rule (72 FR 54208) designating oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro- 4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol) as a basic class in schedule II of the Controlled Substances Act (CSA). The drug code for oripavine was inadvertently designated as 9335, a drug code which is already used to identify a schedule I controlled substance. This correction corrects that error and assigns a different drug code to oripavine.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/12/10/E7-23759/designation-of-oripavine-as-a-basic-class-of-controlled-substance-correction)
---
*AI Analytics · CC0 1.0*